<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Chem Eng and Analytical Science</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BF70D1E4-7D79-470E-8FDA-B260542F605C"><gtr:id>BF70D1E4-7D79-470E-8FDA-B260542F605C</gtr:id><gtr:firstName>Hans</gtr:firstName><gtr:otherNames>Victor</gtr:otherNames><gtr:surname>Westerhoff</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI004688%2F1"><gtr:id>422AEB89-3EE3-4C30-BD30-F9903E23A60C</gtr:id><gtr:title>The systems biology of network stress based on data generated from in vitro differentiated hepatocytes from individual-specific human iPS cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I004688/1</gtr:grantReference><gtr:abstractText>Our liver is the major chemical factory of our body. It removes unwelcome chemical compounds from our body, often after changing them chemically. The catch 22 situation here is that this function of the liver is good for the rest of the body, but potentially bad for the liver itself: during the chemical removal processes, toxic compounds tend to arise that put the liver under even more stress than already produced by the increased work load of the removal of the unwelcome compounds. A major hurdle in understanding how the liver deals with such stresses, has been the difference between human individuals. Due to this difference the response measured in one individual could not be used to predict the response to the stress in a different individual. Individuals differ in a limited but substantial number of small mutations in their DNA, some of which give rise alterations in molecular function of a number of molecules in the body. It has been impossible to relate differences in the response to stress, back to differences in any one of the mutated molecules. As in human societies, processes in living cells are carried out not by individuals but by networks of individuals. This project will therefore try to relate the response to stress of individuals not to their molecules but to their molecular networks. This will be done by a combination of experimentation with ultra modern experimental methods such as deep sequencing and mathematical modelling using fast and well-programmed computers. One result will be a mathematical model that describes part of the function of the liver and hence of the human.</gtr:abstractText><gtr:technicalSummary>The human liver cab be in a variety of stress states ranging from manageable stress as in simple steatosis (S) to excessive stress as in steatohepatitis (SH). A major unsolved problem is the marked difference in the individuals' ability to deal with the stress, e.g. as observed in terms of risk to develop steatohepatitis and to progress to cirrhosis. These differences in susceptibility to SH and its progression to cirrhosis have been attributed to a complex interplay of genetic and environmental factors. The concept underpinning this project is that the various environmental exposures and genetic factors affect many different molecules in many different ways, but have very similar effects on network function. Accordingly, the proposed project will adopt a systems biology approach to develop a computational model for S and SH based on gene expression data generated from individualized in vitro differentiated hepatocytes exposed to various environmental stimuli. To achieve this goal we will employ the recently developed technique to reprogram fibroblasts from skin biopsies into iPS cells (induced Pluripotent Stem cells) employing virus-mediated transduction of the embryonic stem cell specific transcription factors-OCT4, SOX2, KlF4 and c-MYC. The systems biology modelling will address the differentiation of the fibroblasts-derived iPS cells into hepatocyte-like cells, the network stress, the network response to the stress, and to a limited extent the failure of the network to respond to the stress.</gtr:technicalSummary><gtr:potentialImpactText>iPS cells derived from S and SH patients with various genetic or acquired disorders could be used to develop new disease models and increase our meagre knowledge of the underlying mechanisms. They could be eventually used as a source for autologous cell therapies in stem cell-based regenerative medicine. The projected in silico model of steatosis and steatohepatitis comprising its underlying metabolic pathways and regulatory processes can help to understand the disease progression in more detail. The model can foster the identification of potential intervention points for new therapies and thus contribute to the development of new drugs. Supported by the increasing knowledge on genetic variation in the human genome the model can also contribute to a personalized approach to liver stress and personalized therapies medicine of steatohepatitis progression and appropriate therapies for its prevention. The projected in silico model can directly be exploited by the company Alacris Pharmaceutical.</gtr:potentialImpactText><gtr:fund><gtr:end>2013-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>264915</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Mammalian stem cell systems biology</gtr:description><gtr:id>B8165693-7A90-4CDE-BD89-59E2EFC0A52E</gtr:id><gtr:impact>Publications and further grant applications</gtr:impact><gtr:outcomeId>56d9a6cc5f4816.52075934-1</gtr:outcomeId><gtr:partnerContribution>Provision of data and research questions</gtr:partnerContribution><gtr:piContribution>Addition of systems biology expertise</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Inspiration of further research into the use of pluripotent stem cells.</gtr:description><gtr:id>C0BD9C28-56D1-43E7-A8E9-5DD860D80DF9</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d95f11cfff16.67421647</gtr:outcomeId><gtr:sector>Digital/Communication/Information Technologies (including Software),Education,Pharmaceuticals and Medical Biotechnology,Other</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Most living organisms contain thousands of genes. The expression (utilization) of these can be measured experimentally. In this project malfunction of the liver in various individuals has been analyzed in these terms. We found that not only the disease pathways differed between individuals.
The project also fed into others that deal with liver toxicity, that explain human diseases, as well as into a project that made us understand much better how dynamic and subtle the regulation is of the use of the genetic information.</gtr:description><gtr:exploitationPathways>Scientific literature.
Follow-up research projects, which we are applying for.</gtr:exploitationPathways><gtr:id>CFD98E11-5E6C-4E6D-A838-15F7CBAAAD62</gtr:id><gtr:outcomeId>56d95eb1d06c39.69291770</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology,Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Steatosis or fatty liver disease is an important disease sometimes leading to hepatocarcinoma. Most researchers engaged in genomics are searching for so-called candidate genes in their data, which then should identify single-gene causes and single target strategies. We have developed a way to identify/examine 'candidate pathways'.
More inn general, the portfolio of projects ahs led to a great increase in number of detailed kinetic models of metabolic pathways (as reported in JWS-Online). these are now of great use for other organisms and the same pathways or other pathways in the same organisms. All these models are also of use for the development of the Infrastructure Systems Biology Europe (ISBE).</gtr:description><gtr:id>C2AE366A-294B-4733-B25F-6562B840A80A</gtr:id><gtr:impact>This is now used in multiple research projects. Through JWS online and BioModels our models are used by many.</gtr:impact><gtr:outcomeId>58c99951d8a554.74201952</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Candidate pathway finding</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E202FF02-19B3-4F2B-88D3-434868264F9A</gtr:id><gtr:title>Systems biology of chemotherapy in hypoxia environments</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c54fd83abb820761764dfe7f28fb9fc7"><gtr:id>c54fd83abb820761764dfe7f28fb9fc7</gtr:id><gtr:otherNames>Armitage, Emily</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>58bc964e274a02.36356295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A1D4568-CF0A-4775-B51A-D3194B8B54B9</gtr:id><gtr:title>(Im)Perfect robustness and adaptation of metabolic networks subject to metabolic and gene-expression regulation: marrying control engineering with metabolic control analysis.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373d1c654ca2691bb8d71b2cc74294c3"><gtr:id>373d1c654ca2691bb8d71b2cc74294c3</gtr:id><gtr:otherNames>He F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>5675d93ad32dd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32646D99-0001-456A-BB69-A06F82B5F9B6</gtr:id><gtr:title>Multi-factorial disease and robustness: Where Systems Biology makes a difference</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabbf1427d9bc0b52c06f23470a9182d"><gtr:id>dabbf1427d9bc0b52c06f23470a9182d</gtr:id><gtr:otherNames>Westerhoff, H. V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc9651ddee55.21098190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F298CE7-8854-4F84-8992-A424B5D6BAF2</gtr:id><gtr:title>Exploiting metabolic and gene-expression networks for drug design</gtr:title><gtr:parentPublicationTitle>ICOPA XI: Proceedings of the 11th International Congress of Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aa66d3842ff61d076f0a6a55bb4f405"><gtr:id>1aa66d3842ff61d076f0a6a55bb4f405</gtr:id><gtr:otherNames>Albert, M. -A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:isbn>9788875872731</gtr:isbn><gtr:issn>88-7587-272-4</gtr:issn><gtr:outcomeId>58bc9652a9a2f9.20636526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2D1A622-5AB8-4058-8E87-E120A6CB7DFC</gtr:id><gtr:title>Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.</gtr:title><gtr:parentPublicationTitle>Scientific data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c005ea75e6acb36657fc353b743eff0"><gtr:id>2c005ea75e6acb36657fc353b743eff0</gtr:id><gtr:otherNames>Wruck W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2052-4463</gtr:issn><gtr:outcomeId>58bc964d04a064.52807348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>627B28D2-5753-43A9-AF72-BF4BA1A2DBBE</gtr:id><gtr:title>Summation theorems for flux and concentration control coefficients of dynamic systems.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d7d347dc73fdd1e77e7299a0387eb0"><gtr:id>e5d7d347dc73fdd1e77e7299a0387eb0</gtr:id><gtr:otherNames>Conradie R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc9653787c22.07523674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28EE269-8001-410B-A3E9-F84AA12EAC8B</gtr:id><gtr:title>The International Consortium on Systems Biology of Receptor Tyrosine Kinase Regulatory Networks.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ab38fdd1a6b0b207dd26bef25a56c0c"><gtr:id>1ab38fdd1a6b0b207dd26bef25a56c0c</gtr:id><gtr:otherNames>Sakaki Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc96563cdb71.31348304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6066431C-96CE-456F-947D-AE4F1F64DC08</gtr:id><gtr:title>Matrix method for determining steps most rate-limiting to metabolic fluxes in biotechnological processes. 1987.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23e765f696328753cfc7c38cedd990a1"><gtr:id>23e765f696328753cfc7c38cedd990a1</gtr:id><gtr:otherNames>Westerhoff HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>58bc964f9edcf9.25454635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85056EA2-8D02-49E1-99CC-5F73DAC0DA88</gtr:id><gtr:title>Systems biology of HIF metabolism in cancer</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c54fd83abb820761764dfe7f28fb9fc7"><gtr:id>c54fd83abb820761764dfe7f28fb9fc7</gtr:id><gtr:otherNames>Armitage, Emily</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>58bc964dc00128.15006853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>958561D8-41BB-4068-9297-A9F54B19F74E</gtr:id><gtr:title>Systems biology: Robustness through adaption and regeneration</gtr:title><gtr:parentPublicationTitle>Calcified Tissue International</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec50642a6d41865891b96407bb82cae8"><gtr:id>ec50642a6d41865891b96407bb82cae8</gtr:id><gtr:otherNames>Westerhoff, H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58bc9654842935.75549203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5228F3A-A300-4CE2-9FB5-1F333D6EC810</gtr:id><gtr:title>Macromolecular networks and intelligence in microorganisms.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23e765f696328753cfc7c38cedd990a1"><gtr:id>23e765f696328753cfc7c38cedd990a1</gtr:id><gtr:otherNames>Westerhoff HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5675db6f3ac49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F08A5F3-F5E3-4EE5-AC21-F2853E0D5853</gtr:id><gtr:title>Hierarchical regulation</gtr:title><gtr:parentPublicationTitle>Comparative Biochemistry and Physiology a-Molecular &amp; Integrative Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f90e89ee64ed2d201595c14703e019b"><gtr:id>2f90e89ee64ed2d201595c14703e019b</gtr:id><gtr:otherNames>Bakker, B.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1095-6433</gtr:issn><gtr:outcomeId>58bc965317e2a7.02987315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2B8D2B2-C8C9-43DF-BFA8-9ED8B23B219A</gtr:id><gtr:title>Systems biology-based drug design: Control of oncogenic signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Association for Cancer Research Annual Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/921551cc42c96dc60d7ce0d6e0a3b40f"><gtr:id>921551cc42c96dc60d7ce0d6e0a3b40f</gtr:id><gtr:otherNames>Bruggeman, Frank J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0197-016X</gtr:issn><gtr:outcomeId>58bc965431be25.07038140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E62B6065-8FAE-4062-AEFB-6BDFAFAA8FAD</gtr:id><gtr:title>Metabolite profiling of CHO cells: Molecular reflections of bioprocessing effectiveness.</gtr:title><gtr:parentPublicationTitle>Biotechnology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d829ca2d994c06fc53f22e5cc5eef86e"><gtr:id>d829ca2d994c06fc53f22e5cc5eef86e</gtr:id><gtr:otherNames>Sellick CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1860-6768</gtr:issn><gtr:outcomeId>56d4ca47112531.19052760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E851FB5-A349-4702-941C-7DB1CD208070</gtr:id><gtr:title>A new regulatory principle for in vivo biochemistry: pleiotropic low affinity regulation by the adenine nucleotides--illustrated for the glycolytic enzymes of Saccharomyces cerevisiae.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f6917a389f181473818df9c837a3eda"><gtr:id>7f6917a389f181473818df9c837a3eda</gtr:id><gtr:otherNames>Mensonides FI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>5675d892c81d0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A709DD58-2F6E-4D6C-994C-505F53671345</gtr:id><gtr:title>Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723f7a25a754a6ed7fdfa08a5b918308"><gtr:id>723f7a25a754a6ed7fdfa08a5b918308</gtr:id><gtr:otherNames>Rehman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>5675d74cce384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DCCE060-D75B-4569-8FC0-42205807B9D2</gtr:id><gtr:title>Battling robustness: to make microbes weak</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabbf1427d9bc0b52c06f23470a9182d"><gtr:id>dabbf1427d9bc0b52c06f23470a9182d</gtr:id><gtr:otherNames>Westerhoff, H. V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc965009de00.54790075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BC375C9-AB71-4188-A0F2-2B1AE4082D0E</gtr:id><gtr:title>Nuclear receptors as controlling factors in chemical metabolism: Determination of regulatory signal network crucial for co-ordinating cellular response to chemicals</gtr:title><gtr:parentPublicationTitle>Drug Metabolism Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261a1412a1a035a93edb921b99c38cfc"><gtr:id>261a1412a1a035a93edb921b99c38cfc</gtr:id><gtr:otherNames>Bruggeman, Frank</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0360-2532</gtr:issn><gtr:outcomeId>58bc964ec85815.69341880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36AB97AF-730B-4E78-87FF-D3301C6DD46F</gtr:id><gtr:title>Targeting pathogen metabolism without collateral damage to the host.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b284bb7cbe0495e1d33020a8ad8f4ad"><gtr:id>1b284bb7cbe0495e1d33020a8ad8f4ad</gtr:id><gtr:otherNames>Haanstra JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bc964b773612.42939997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A1A679-2517-4466-AEBD-E0453E7FC7E9</gtr:id><gtr:title>Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97f217f2f4312e072c8112fff6185808"><gtr:id>97f217f2f4312e072c8112fff6185808</gtr:id><gtr:otherNames>Dols JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58bc964ca369b1.07659178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF28F775-C3AE-421D-8172-829142B472D9</gtr:id><gtr:title>Metabolite profiling of CHO cells: Molecular reflections of bioprocessing effectiveness.</gtr:title><gtr:parentPublicationTitle>Biotechnology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d829ca2d994c06fc53f22e5cc5eef86e"><gtr:id>d829ca2d994c06fc53f22e5cc5eef86e</gtr:id><gtr:otherNames>Sellick CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1860-6768</gtr:issn><gtr:outcomeId>56d98178418a10.76174990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20433801-3020-45E8-9A37-BDE542FEF498</gtr:id><gtr:title>Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15fc714b73d80ff53da7e7f6c9282368"><gtr:id>15fc714b73d80ff53da7e7f6c9282368</gtr:id><gtr:otherNames>Geenen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>5675d8453f5d4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B6C548B-DA10-40AE-9FCF-5859BCDA0CBC</gtr:id><gtr:title>MUFINS: multi-formalism interaction network simulator.</gtr:title><gtr:parentPublicationTitle>NPJ systems biology and applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d32428cc153e7cee2d830d508f768769"><gtr:id>d32428cc153e7cee2d830d508f768769</gtr:id><gtr:otherNames>Wu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2056-7189</gtr:issn><gtr:outcomeId>58bc964c455f47.75583607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9AF04B8-3025-4836-B5C6-F5FC8FACCBF3</gtr:id><gtr:title>Glutathione metabolism modeling: a mechanism for liver drug-robustness and a new biomarker strategy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15fc714b73d80ff53da7e7f6c9282368"><gtr:id>15fc714b73d80ff53da7e7f6c9282368</gtr:id><gtr:otherNames>Geenen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56d4ca49016964.78927910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E0C471C-BAD9-4F40-B2AC-9868EDE07B39</gtr:id><gtr:title>Modular Kinetic Analysis of the Adenine Nucleotide Translocator-Mediated Effects of Palmitoyl-CoA on the Oxidative Phosphorylation in Isolated Rat Liver Mitochondria</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e45c451fdbf2325b07977d58e008d56"><gtr:id>5e45c451fdbf2325b07977d58e008d56</gtr:id><gtr:otherNames>Ciapaite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58bc96554315d0.22506347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>370161C0-B687-4784-BAC0-EA8AFA754655</gtr:id><gtr:title>Systems Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cbba07be8f17855eaadf39b7b412334"><gtr:id>1cbba07be8f17855eaadf39b7b412334</gtr:id><gtr:otherNames>Westerhoff H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0947-6075;978-3-540-</gtr:issn><gtr:outcomeId>58bc96524868c3.62272612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1093BDD-04BB-496D-B856-B1923E56D5F0</gtr:id><gtr:title>Adenine nucleotide translocator - A candidate for mediating long chain acyl-CoA effects in type 2 diabetes</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32906616eaf2c7fe96ac926ae1b65420"><gtr:id>32906616eaf2c7fe96ac926ae1b65420</gtr:id><gtr:otherNames>Bakker, S. J. L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc9650d39f28.64246868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A4F4F2D-C9A2-404A-B3E3-FDD9F76A93CA</gtr:id><gtr:title>Structural and dynamic features of the eukaryotic translation initiation pathway</gtr:title><gtr:parentPublicationTitle>Febs Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/789bbc99bc1d25fa91cedd08357426f5"><gtr:id>789bbc99bc1d25fa91cedd08357426f5</gtr:id><gtr:otherNames>Bryant, H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>58bc965072f046.34088598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D46BBE3-0B7B-4F13-BFDD-138F238DA279</gtr:id><gtr:title>Introduction to systems biology.</gtr:title><gtr:parentPublicationTitle>Exs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09ec9b2473024b18b64be38fbdc32f9"><gtr:id>b09ec9b2473024b18b64be38fbdc32f9</gtr:id><gtr:otherNames>Boogerd, Fred C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1023-294X</gtr:issn><gtr:outcomeId>58bc96513811f8.49281426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9719853-C8D3-42D3-81B5-68BE2F0534B7</gtr:id><gtr:title>Systems Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/118b05f3d81d118c4ad89dcef7fd1505"><gtr:id>118b05f3d81d118c4ad89dcef7fd1505</gtr:id><gtr:otherNames>Snoep J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1610-2096</gtr:issn><gtr:outcomeId>58bc9654e1bbf9.88065253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F46641-D7B0-4B0D-A182-FFFFD090B6EE</gtr:id><gtr:title>Multiplex Eukaryotic Transcription (In)activation: Timing, Bursting and Cycling of a Ratchet Clock Mechanism.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c318454a4163b588f43a2d85477a4d6c"><gtr:id>c318454a4163b588f43a2d85477a4d6c</gtr:id><gtr:otherNames>Rybakova KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>56d4ca479a7ee5.16644707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>441626D2-DA07-4349-B540-72A4D041D1B7</gtr:id><gtr:title>Metabolic control analysis to identify optimal drug targets.</gtr:title><gtr:parentPublicationTitle>Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8225ab7ff2537ec2036411646bf0c83"><gtr:id>d8225ab7ff2537ec2036411646bf0c83</gtr:id><gtr:otherNames>Hornberg JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0071-786X</gtr:issn><gtr:outcomeId>58bc96518eaf34.49369557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CADB3BD2-38AB-473D-8E0B-EE5BF5250497</gtr:id><gtr:title>Sulfolobus Systems Biology: Cool Hot Design for Metabolic Pathways</gtr:title><gtr:parentPublicationTitle>Systems Microbiology: Current Topics and Applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39156294cb308686f463b4acfea1a2b4"><gtr:id>39156294cb308686f463b4acfea1a2b4</gtr:id><gtr:otherNames>Kolodkin, Alexey</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-908230-02-7</gtr:isbn><gtr:issn>978-1-908230-02-7</gtr:issn><gtr:outcomeId>58bc964d65d931.64051831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>959B2BC8-3223-46A6-B6C7-32D0BE1C8B5A</gtr:id><gtr:title>Control of kinases and phosphatases on signaling kinetics.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Association for Cancer Research Annual Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf170fc7a1f9eb543f3abab853cc1402"><gtr:id>bf170fc7a1f9eb543f3abab853cc1402</gtr:id><gtr:otherNames>Binder, Bernd</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0197-016X</gtr:issn><gtr:outcomeId>58bc96568e0b75.81697163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88850F1A-B7A2-4318-B698-83E9F4CE5402</gtr:id><gtr:title>Tracing the molecular basis of transcriptional dynamics in noisy data by using an experiment-based mathematical model.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c318454a4163b588f43a2d85477a4d6c"><gtr:id>c318454a4163b588f43a2d85477a4d6c</gtr:id><gtr:otherNames>Rybakova KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56d4ca48359837.31407481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D77B5A-3EA1-4E0A-AEDA-E6FE04644ABF</gtr:id><gtr:title>A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29b0d3abdea5b60ddd326d0c1f506bf3"><gtr:id>29b0d3abdea5b60ddd326d0c1f506bf3</gtr:id><gtr:otherNames>Jozefczuk J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>56d4ca4a4dd0d7.76877173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E24F1D6-7346-47D7-99EC-0875E77814D5</gtr:id><gtr:title>Report of an EU projects workshop on systems biology held in Brussels, Belgium on 8 December 2004.</gtr:title><gtr:parentPublicationTitle>Systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0750d92ab622a1e68d3236e9e5783428"><gtr:id>0750d92ab622a1e68d3236e9e5783428</gtr:id><gtr:otherNames>Birney E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1741-2471</gtr:issn><gtr:outcomeId>58bc96559fb537.52010166</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I004688/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>